Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Priority Technology Holdings (NASDAQ: PRTH) Sets $8.05 Cash Merger

On September 18, 2026, it agreed to merge with WD Capital Partners Merger Sub, leaving Priority Technology Holdings (NASDAQ: PRTH) as a wholly owned subsidiary of Parent. Eligible common shares will convert into the right to receive $8.05 per share in cash.

Vinay Lochav | 21 September 2026

TIM S.A. (NYSE: TIMB) Sets September 21-25 Window for Telecom Italia Offer

TIM S.A. (NYSE: TIMB) is a wireless telecommunications company. Poste Italiane became the indirect controlling shareholder of TIM Brasil after its combined interest in Telecom Italia S.p.A. Reached approximately 66.627% of Telecom Italia’s share capital.

Vinay Lochav | 21 September 2026

RECURSION PHARMACEUTICALS (NASDAQ: RXRX) Cuts Tempus Fees to $14M

RECURSION PHARMACEUTICALS, INC. (NASDAQ: RXRX) is a biotechnology company. The company revised its agreement with Tempus AI, Inc. (NASDAQ: TEM) replacing the previous annual-fee structure with $14,000,000 payments for each of the third, fourth and fifth anniversaries of the effective date.

Vinay Lochav | 21 September 2026

Scinai (NASDAQ: SCNI) ADSs Meet Nasdaq $1.00 Bid Requirement

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is a Pharmaceuticals: Other company. Its American Depositary Shares have regained compliance with Nasdaq’s $1.00 minimum bid-price requirement, and Nasdaq has closed the matter.

Vinay Lochav | 21 September 2026

AXON Enterprise (NASDAQ: AXON) Issues $1.15B Convertible Notes at 0%

The amount includes $150.0 million issued under the underwriters’ fully exercised over-allotment option. The notes do not pay regular interest or increase in principal, and mature on September 15, 2031, unless converted, redeemed or repurchased earlier.

Vinay Lochav | 21 September 2026

ASTRAZENECA PLC (NYSE: AZN) Klygefa Gets CHMP Nod; 82,500 gMG Cases

ASTRAZENECA PLC (NYSE: AZN) is a Pharmaceuticals: Major company. Klygefa (gefurulimab) has received a positive recommendation for European Union approval in adults with anti-acetylcholine receptor antibody-positive generalised myasthenia gravis. The proposed use is as an add-on to standard therapy.

Vinay Lochav | 21 September 2026

ASTRAZENECA PLC (NYSE: AZN) Enhertu EU Recommendation Shows 53% Lower Risk of Recurrence or Death

ASTRAZENECA PLC (NYSE: AZN) is a major pharmaceuticals company. Enhertu has received a positive recommendation in theEuropean Unionfor adults with residual invasive HER2-positive early breast cancer after neoadjuvant treatment, with DESTINY-Breast05 showing a 53% reduction in invasive disease recurrence or death versus T-DM1. The …

Vinay Lochav | 21 September 2026

DR REDDYS LABORATORIES LTD Sets Nomura Investor Meeting

Management will participate in a Nomura investor meeting in Hyderabad on 25.09.2026, with the in-person session set for 11:00 to 14:00 IST.

Vinay Lochav | 21 September 2026

MindWalk (NASDAQ: HYFT) Brings OpenFold3 Into Production With AMD and Vultr

MindWalk Holdings Corp. (NASDAQ: HYFT) is a biotechnology company. The company has moved the open-source OpenFold3 structure-prediction model into a production deployment using AMD and Vultr infrastructure, testing the complete workflow inside its discovery operations.

Vinay Lochav | 21 September 2026

Nuran Wireless (NASDAQ: NUR) Updates Annual Information Form for Investors

Nuran Wireless Inc. (NASDAQ: NUR) is an electronics distributor. Its amended and restated Annual Information Form is dated June 4, 2026, while the information covered is current as of December 31, 2025.

Vinay Lochav | 21 September 2026
Support

Hi! How can we help you today?

Loading…